Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel DuPage

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|November 24, 2025
MAIT cells induced by engineered <i>Listeria</i> exhibit antibacterial and antitumor activityRafael Rivera-Lugo, Jesse Garcia Castillo, Mariya Lobanovska, et al.
Immunity|June 6, 2025
Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapyJesse Garcia Castillo, Sebastian Fernandez, Timothy Campbell, et al.
Science Advances|January 23, 2026
Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunityJesse Garcia Castillo, Stephanie Silveria, Leo Schirokauer, et al.
Immunity|February 15, 2015
The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activationMichel DuPage, Gaurav Chopra, Jason Quiros, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapyJesse Garcia Castillo, Sebastian Fernandez, Timothy Campbell, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
TLR2 signaling uniquely destabilizes tumor Tregs to promote cancer immunotherapyTimothy F Campbell, Jesse Garcia Castillo, Sebastian Fernandez, et al.
Science Advances|September 26, 2025
Age-related remodeling of the sialoglycans dampens murine CD8<sup>+</sup> T cell functionHanlin Zhang, C Kimberly Tsui, Jesse Garcia Castillo, et al.
Science Immunology|April 10, 2026
Intratumoral T<sub>reg</sub> cell ablation elicits NK cell-mediated control of CD8 T cell-resistant tumorsChenyu Zhang, Charles Chien, Eglė Jurgaitytė, et al.
Nature Immunology|January 7, 2015
Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stabilityAlexandria Huynh, Michel DuPage, Bhavana Priyadharshini, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Intra-Tumoral Treg Ablation Unleashes NK Cell-Mediated Control of CD8 T Cell-Resistant TumorsChenyu Zhang, Charles Chien, Eglė Jurgaitytė, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|November 24, 2025
MAIT cells induced by engineered <i>Listeria</i> exhibit antibacterial and antitumor activityRafael Rivera-Lugo, Jesse Garcia Castillo, Mariya Lobanovska, et al.
Immunity|June 6, 2025
Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapyJesse Garcia Castillo, Sebastian Fernandez, Timothy Campbell, et al.
Science Advances|January 23, 2026
Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunityJesse Garcia Castillo, Stephanie Silveria, Leo Schirokauer, et al.
Immunity|February 15, 2015
The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activationMichel DuPage, Gaurav Chopra, Jason Quiros, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapyJesse Garcia Castillo, Sebastian Fernandez, Timothy Campbell, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
TLR2 signaling uniquely destabilizes tumor Tregs to promote cancer immunotherapyTimothy F Campbell, Jesse Garcia Castillo, Sebastian Fernandez, et al.
Science Advances|September 26, 2025
Age-related remodeling of the sialoglycans dampens murine CD8<sup>+</sup> T cell functionHanlin Zhang, C Kimberly Tsui, Jesse Garcia Castillo, et al.
Science Immunology|April 10, 2026
Intratumoral T<sub>reg</sub> cell ablation elicits NK cell-mediated control of CD8 T cell-resistant tumorsChenyu Zhang, Charles Chien, Eglė Jurgaitytė, et al.
Nature Immunology|January 7, 2015
Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stabilityAlexandria Huynh, Michel DuPage, Bhavana Priyadharshini, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Intra-Tumoral Treg Ablation Unleashes NK Cell-Mediated Control of CD8 T Cell-Resistant TumorsChenyu Zhang, Charles Chien, Eglė Jurgaitytė, et al.
Pageof 4